First- and second-trimester down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): A FASTER trial study

Prenatal Diagnosis

Volumn 26, Issue 8, 2006, Pages 672-678

  Lambert Messerlian, G ^a   Dugoff, L ^b   Vidaver, J ^c   Canick, J A ^a   Malone, F D ^d   Ball, R H ^e   Comstock, C H ^f   Nyberg, D A ^g   Saade, G ^h   Eddleman, K ⁱ   Klugman, S ^j   Craigo, S D ^k   Timor Tritsch, I E ^l   Carr, S R ^a   Wolfe, H M ^m   D'Alton, M E ^d  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DM STAT Inc   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f WILLIAM BEAUMONT HOSPITAL   (United States)

^g SWEDISH MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^k TUFTS UNIVERSITY   (United States)

^l NEW YORK UNIVERSITY   (United States)

^m UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

Assisted reproduction; Down syndrome; Maternal serum screening; Pregnancy

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PROTEIN;

ARTICLE; ASSISTIVE TECHNOLOGY; CONTROLLED STUDY; DOWN SYNDROME; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INFERTILITY THERAPY; INTERMETHOD COMPARISON; INTRAUTERINE INSEMINATION; OVULATION INDUCTION; PRIORITY JOURNAL; RANK SUM TEST; SCREENING; SECOND TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; DATABASES, FACTUAL; DOWN SYNDROME; FEMALE; FERTILIZATION IN VITRO; HUMANS; MASS SCREENING; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND;

EID: 33747420322     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1469     Document Type: Article

References (29)

1. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. 1996. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 16: 1111-1114.
2. Bellver J, Lara C, Soares SR, et al. 2005. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 20: 2623-2627.
3. Bersinger NA, Wunder D, Vanderlick F, et al. 2004. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening. Prenat Diagn 24: 471-477.
4. Canick JA, MacRae AR. 2005. Second trimester serum markers. Semin Perinatol 29: 203-208.
5. Cuckle HS, Spencer K, Nicolaides KH. 2005. Down syndrome screening marker levels in women with a previous aneuploidy pregnancy. Prenat Diagn 25: 47-50.
6. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN Jr. 1997. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
7. Ghisoni L, Ferrazi E, Castagna C, Levi Setti PE, Masini AC, Pigni A. 2003. Prenatal diagnosis after ART success: the role of early combined screening tests in counseling patients. Placenta 24: S99-103.
8. Hsu T-Y, Ou CY, Hsu JJ, Kung FT, Chang SY, Soong YK. 1999. Maternal serum screening for Down syndrome in pregnancies conceived by intrauterine insemination. Prenat Diagn 19: 1012-1014.
9. Hui PW, Tang MHY, Lam YH, Ng EHY, Yeung WSB, Ho PC. 2003. Maternal serum hCG and alpha-fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen-thawed embryos. Hum Reprod 18(3): 572-575.
10. Hui PW, Tang MHY, Lam YH, Yeung WSB, Ng EHY, Ho PC. 2005. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 25: 234-238.
11. Lam YH, Yeung WSB, Tang MHY, Ng EHY, So WWK, Ho PC. 1999. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod 14(8): 2120-2123.
12. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. 2001. First trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16(7): 1501-1504.
13. Malone FD, Canick JA, Ball RH, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
14. Maymon R, Shulman A. 2001. Comparison of triple marker serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 16(4): 691-695.
15. Maymon R, Jauniaux E. 2002. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed Online 4: 285-293.
16. Maymon R, Shulman A. 2002. Serial first- and second-trimester Down's syndrome screening tests among IVF- versus naturally-conceived singletons. Hum Reprod 17(4): 1081-1085.
17. Maymon R, Shulman A. 2004. Integrated first and second trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 24: 125-129.
18. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. 1999. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Prenat Diagn 19: 1007-1011.
19. Muller F, Dreux S, Lemeur A, et al. The French Collaborative Group. 2003. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn 23: 1073-1076.
20. Nicolaides KH. 2004. Nuchal translucency and other first-trimester sonographic markers of chromosome abnormalities. Am J Obstet Gynecol 191: 45-67.
21. Olandi F, Rossi C, Allegra A, et al. 2002. First trimester screening with free ∃-hCG, PAPP-A, and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22: 718-721.
22. Raty R, Ekblad U, Anttila L, et al. 2001. Maternal serum ∃-hCG levels in screening for Down syndrome are higher in singleton pregnancies achieved with ovulation induction and intrauterine insemination than in spontaneous singleton pregnancies. Fertil Steril 76: 1075-1077.
23. Raty R, Virtanen A, Koskinen P, et al. 2002. Serum free ∃-hCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum Reprod 17: 481-484.
24. Rice JD, McIntosh SF, Halstead AC. 2005. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Prenat Diagn 25: 234-238.
25. Shulman A, Maymon R. 2003. Mid-gestation Down syndrome screening test and pregnancy outcome among unstimulated assisted-conception pregnancies. Prenat Diagn 23: 625-628.
26. Wald N. 2000. Down's syndrome. In Antenatal and Neonatal Screening, Wald N, Leck I (eds). Oxford University Press: Oxford 85-115.
27. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. 1999. Serum markers for Down's syndrome in women who have had in vitro fertilization: implications for antenatal screening. Br J Obstet Gynaecol 106: 1304-1306.
28. Wenstrom KD. 2005. First-trimester Down syndrome screening: component analytes and timing for optimal performance. Semin Perinatol 29: 195-202.
29. Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. 2001. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 21: 563-565.